Home
Newsletter
Events
Blogs
Reports
Graphics
RSS
About Us
Support
Write for Us
Media Info
Advertising Info
Drug factories

Generic Drug Plant Caught Falsifying Data

Tuesday, May 26, 2009 by: David Gutierrez, staff writer
Tags: drug factories, health news, Natural News


Most Viewed Articles
https://www.naturalnews.com/026326_drug_drugs_United_States.html
Delicious
diaspora
Print
Email
Share

(NaturalNews) The FDA has ordered a halt to approvals of drugs relying on data from a generic drug factory in India that was found to be falsifying data.

"We took this action after it became apparent that this facility was submitting falsified scientific data in applications for FDA approval of marketed drugs in the United States," said Douglas Throckmorton, deputy director of the FDA's Center for Drug Evaluation and Research.

The facility in question, Paonta Sahib, is operated by Ranbaxy Laboratories, one of the largest makers of generic drugs for the United States. The Paonta Sahib lab, along with another facility in Dewas, India, was also involved in a September scandal, in which the FDA placed a hold on importation of 30 products from the plants due to suspected contamination during the manufacturing process.

Now Paonta Sahib has been implicated in supplying false data -- such as fake shelf life figures -- in applications for approval of its generic drugs. In response, the FDA has placed a hold on the approval or consideration of any new applications involving the plant.

The applications on hold include approval for drugs manufactured in the United States using data from the plant as well as for drugs manufactured at the plant itself -- including generic versions of currently approved drugs and drugs not currently marketed in the United States.

The FDA is also seeking confirmation that no Ranbaxy products currently manufactured in the United States relied for their approval on data from the Paonta Sahib plant. These products include the cholesterol drugs imvastatin (also known as simvastatin) and pravastatin (a generic form of Pravachol), and the antihistamine pheniramine (a generic form of Avil).

The agency cautioned patients taking these drugs not to stop using them without consulting a physician first. No reports of harm have been received from Ranbaxy products made at Paonta Sahib or in the United States, according to Deborah Autor, director of the Center for Drug Evaluation and Research's Office of Compliance.

Sources for this story include: health.usnews.com.

Receive Our Free Email Newsletter

Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.


comments powered by Disqus



Natural News Wire (Sponsored Content)

Science.News
Science News & Studies
Medicine.News
Medicine News and Information
Food.News
Food News & Studies
Health.News
Health News & Studies
Herbs.News
Herbs News & Information
Pollution.News
Pollution News & Studies
Cancer.News
Cancer News & Studies
Climate.News
Climate News & Studies
Survival.News
Survival News & Information
Gear.News
Gear News & Information
Glitch.News
News covering technology, stocks, hackers, and more